US Stock MarketDetailed Quotes

MREO Mereo BioPharma

Watchlist
  • 3.8100
  • +0.4200+12.39%
Close Dec 24 13:00 ET
591.10MMarket Cap-12.70P/E (TTM)

Mereo BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
10M
1M
0
9M
0
0
49.21M
Operating revenue
--0
--0
--0
--10M
--1M
--0
--9M
--0
--0
--49.21M
Cost of revenue
0
0
0
324.61%2.57M
-273K
-235K
3.43M
-347K
-104.74%-1.15M
24.17M
Gross profit
0
0
0
547.99%7.43M
1.27M
235K
5.57M
347K
-95.42%1.15M
25.04M
Operating expense
-0.79%9.15M
116.06%12.45M
-16.30%9.42M
-35.81%34.56M
8.32M
9.22M
5.76M
11.26M
1.02%53.84M
4.10%53.3M
Selling and administrative expenses
8.67%6.2M
194.79%7.87M
-8.43%5.91M
-29.43%18.42M
--3.6M
--5.71M
--2.67M
--6.45M
21.41%26.11M
-25.65%21.5M
-General and administrative expense
8.67%6.2M
194.79%7.87M
-8.43%5.91M
-29.43%18.42M
--3.6M
--5.71M
--2.67M
--6.45M
21.41%26.11M
-25.65%21.5M
Research and development costs
-11.80%3.17M
33.24%4.95M
-24.74%3.99M
-40.89%17.42M
--4.8M
--3.59M
--3.71M
--5.31M
-7.33%29.47M
42.72%31.8M
Other operating expenses
-175.61%-226K
40.58%-369K
4.41%-477K
25.93%-1.28M
---78K
---82K
---621K
---499K
---1.73M
----
Operating profit
-1.80%-9.15M
-6,450.00%-12.45M
13.64%-9.42M
48.51%-27.14M
-7.05M
-8.99M
-190K
-10.91M
-86.50%-52.7M
44.81%-28.26M
Net non-operating interest income expense
5,827.27%630K
134.76%228K
162.15%307K
77.51%-750K
410K
-11K
-656K
-494K
38.55%-3.34M
37.18%-5.43M
Non-operating interest income
42.67%983K
49.87%559K
101.63%617K
153.69%2.13M
--763K
--689K
--373K
--306K
62,138.96%840K
-80.19%1.35K
Non-operating interest expense
-49.57%353K
-67.83%331K
-61.25%310K
-30.99%2.88M
--353K
--700K
--1.03M
--800K
-22.68%4.18M
-37.92%5.4M
Total other finance cost
----
----
----
----
----
----
----
----
----
153.33%28.34K
Other net income (expense)
-363.04%-6.48M
95.80%-38K
124.59%165K
-116.13%-2.11M
-3M
2.47M
-905K
-671K
-75.25%13.1M
131.68%52.9M
Gain on sale of security
-363.04%-6.48M
95.80%-38K
124.81%165K
-117.50%-2.1M
---3M
--2.47M
---905K
---665K
-77.23%12.01M
134.66%52.75M
Special income (charges)
----
----
----
----
----
----
----
----
----
101.03%152.51K
-Gain on sale of property,plant,equipment
----
----
----
----
----
----
----
----
----
101.03%152.51K
Other non- operating income (expenses)
----
----
----
-100.92%-10K
---4K
----
----
---6K
--1.09M
----
Income before tax
-129.69%-15M
-599.89%-12.26M
25.88%-8.95M
30.14%-30M
-9.64M
-6.53M
-1.75M
-12.08M
-323.40%-42.94M
108.47%19.22M
Income tax
0
0
0
25.91%-532K
-532K
0
0
0
-135.09%-718K
153.20%2.05M
Net income
-129.69%-15M
-599.89%-12.26M
25.88%-8.95M
30.21%-29.47M
-9.11M
-6.53M
-1.75M
-12.08M
-345.83%-42.22M
107.70%17.17M
Net income continuous Operations
-129.69%-15M
-599.89%-12.26M
25.88%-8.95M
30.21%-29.47M
---9.11M
---6.53M
---1.75M
---12.08M
-345.83%-42.22M
107.70%17.17M
Minority interest income
Net income attributable to the parent company
-129.69%-15M
-599.89%-12.26M
25.88%-8.95M
30.21%-29.47M
-9.11M
-6.53M
-1.75M
-12.08M
-345.83%-42.22M
107.70%17.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-129.69%-15M
-599.89%-12.26M
25.88%-8.95M
30.21%-29.47M
-9.11M
-6.53M
-1.75M
-12.08M
-345.83%-42.22M
107.70%17.17M
Basic earnings per share
-100.00%-0.1
-617.77%-0.1
50.00%-0.05
42.86%-0.2
-0.05
-0.05
-0.0139
-0.1
-359.33%-0.35
104.13%0.135
Diluted earnings per share
-100.00%-0.1
-617.77%-0.1
50.00%-0.05
42.86%-0.2
-0.05
-0.05
-0.0139
-0.1
-3.73%-0.35
89.68%-0.3374
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 00010M1M09M0049.21M
Operating revenue --0--0--0--10M--1M--0--9M--0--0--49.21M
Cost of revenue 000324.61%2.57M-273K-235K3.43M-347K-104.74%-1.15M24.17M
Gross profit 000547.99%7.43M1.27M235K5.57M347K-95.42%1.15M25.04M
Operating expense -0.79%9.15M116.06%12.45M-16.30%9.42M-35.81%34.56M8.32M9.22M5.76M11.26M1.02%53.84M4.10%53.3M
Selling and administrative expenses 8.67%6.2M194.79%7.87M-8.43%5.91M-29.43%18.42M--3.6M--5.71M--2.67M--6.45M21.41%26.11M-25.65%21.5M
-General and administrative expense 8.67%6.2M194.79%7.87M-8.43%5.91M-29.43%18.42M--3.6M--5.71M--2.67M--6.45M21.41%26.11M-25.65%21.5M
Research and development costs -11.80%3.17M33.24%4.95M-24.74%3.99M-40.89%17.42M--4.8M--3.59M--3.71M--5.31M-7.33%29.47M42.72%31.8M
Other operating expenses -175.61%-226K40.58%-369K4.41%-477K25.93%-1.28M---78K---82K---621K---499K---1.73M----
Operating profit -1.80%-9.15M-6,450.00%-12.45M13.64%-9.42M48.51%-27.14M-7.05M-8.99M-190K-10.91M-86.50%-52.7M44.81%-28.26M
Net non-operating interest income expense 5,827.27%630K134.76%228K162.15%307K77.51%-750K410K-11K-656K-494K38.55%-3.34M37.18%-5.43M
Non-operating interest income 42.67%983K49.87%559K101.63%617K153.69%2.13M--763K--689K--373K--306K62,138.96%840K-80.19%1.35K
Non-operating interest expense -49.57%353K-67.83%331K-61.25%310K-30.99%2.88M--353K--700K--1.03M--800K-22.68%4.18M-37.92%5.4M
Total other finance cost ------------------------------------153.33%28.34K
Other net income (expense) -363.04%-6.48M95.80%-38K124.59%165K-116.13%-2.11M-3M2.47M-905K-671K-75.25%13.1M131.68%52.9M
Gain on sale of security -363.04%-6.48M95.80%-38K124.81%165K-117.50%-2.1M---3M--2.47M---905K---665K-77.23%12.01M134.66%52.75M
Special income (charges) ------------------------------------101.03%152.51K
-Gain on sale of property,plant,equipment ------------------------------------101.03%152.51K
Other non- operating income (expenses) -------------100.92%-10K---4K-----------6K--1.09M----
Income before tax -129.69%-15M-599.89%-12.26M25.88%-8.95M30.14%-30M-9.64M-6.53M-1.75M-12.08M-323.40%-42.94M108.47%19.22M
Income tax 00025.91%-532K-532K000-135.09%-718K153.20%2.05M
Net income -129.69%-15M-599.89%-12.26M25.88%-8.95M30.21%-29.47M-9.11M-6.53M-1.75M-12.08M-345.83%-42.22M107.70%17.17M
Net income continuous Operations -129.69%-15M-599.89%-12.26M25.88%-8.95M30.21%-29.47M---9.11M---6.53M---1.75M---12.08M-345.83%-42.22M107.70%17.17M
Minority interest income
Net income attributable to the parent company -129.69%-15M-599.89%-12.26M25.88%-8.95M30.21%-29.47M-9.11M-6.53M-1.75M-12.08M-345.83%-42.22M107.70%17.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -129.69%-15M-599.89%-12.26M25.88%-8.95M30.21%-29.47M-9.11M-6.53M-1.75M-12.08M-345.83%-42.22M107.70%17.17M
Basic earnings per share -100.00%-0.1-617.77%-0.150.00%-0.0542.86%-0.2-0.05-0.05-0.0139-0.1-359.33%-0.35104.13%0.135
Diluted earnings per share -100.00%-0.1-617.77%-0.150.00%-0.0542.86%-0.2-0.05-0.05-0.0139-0.1-3.73%-0.3589.68%-0.3374
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.53%